ARCHIVES

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004

Clearinghouse Role Broadened By Upton; Asked To Consider All Data In Risk Assessment

November 11, 1977

Ontak Approved For Lymphoma

October 31, 2008

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

Advisors say NCI needs to reach out to other fields.

July 15, 2005